Search


Ireland HPRA’s Guide: Good Distribution Practice (GDP) of Medicinal Products
The Health Products Regulatory Authority (HPRA) of Ireland released Version 8 of its Guide to Good Distribution Practice (GDP) in March...

Sharan Murugan
May 33 min read
22 views
0 comments


Announcing Veeva AI: A Bold Leap Toward Intelligent Automation in Life Sciences
The world of pharma and life sciences is abuzz with a major announcement: Veeva Systems has just unveiled Veeva AI , a groundbreaking...

Sharan Murugan
Apr 293 min read
129 views
0 comments


USFDA Public Consultation: HL7 FHIR for Study Data from Real-World Data
The U.S. Food and Drug Administration (FDA)Â has announced a major initiative by opening a public docket seeking comments on the "...

Sharan Murugan
Apr 273 min read
32 views
0 comments
Australia's TGA Guidance Blog: Labelling and Presentation Requirements for Listed Medicines
On 9 April 2025, the Therapeutic Goods Administration (TGA) released updated guidance titled “ Understanding Labelling and Presentation...

Sharan Murugan
Apr 233 min read
56 views
0 comments


SFDA Guidance: Requirements for Formal Meetings Between the Drug Sector and Applicants
Th e Saudi Food and Drug Authority (SFDA)Â has issued an updated version (3.1, dated 7 April 2025) of its guideline: " Requirements for...

Sharan Murugan
Apr 232 min read
17 views
0 comments


ICH Guidance Q1: Stability Testing of Drug Substances and Drug Products (Step 2 Draft 2025)- Public Consultation
The International Council for Harmonisation (ICH) has released a significant update to its stability testing guidelines, consolidating...

Sharan Murugan
Apr 182 min read
171 views
0 comments


EMA Guidance: Anonymisation and Confidentiality in Risk Management Plans (RMPs)
The European Medicines Agency (EMA)Â has published a revised guideline titled " Guidance on the Anonymisation of Protected Personal Data...

Sharan Murugan
Apr 184 min read
25 views
0 comments


EMA Guidance: Procedural Advice on Paediatric Applications
The European Medicines Agency (EMA) has issued updated guidance " Procedural advice on Paediatric Applications " to support stakeholders...

Sharan Murugan
Apr 183 min read
49 views
0 comments


UK MHRA Guidance: Risk Minimisation Measures for Medicines
The Medicines and Healthcare products Regulatory Agency (MHRA)Â has published updated guidance on " Risk Minimisation Measures (RMMs)Â for...

Sharan Murugan
Apr 182 min read
25 views
0 comments


UK MHRA Guidance: How to Notify a Clinical Investigation for a Medical Device & CTR Signed to Law
Before starting any clinical investigation involving a medical device in the UK, it is a legal requirement to notify the Medicines and...

Sharan Murugan
Apr 183 min read
9 views
0 comments


Medical Devices: Post-Market Surveillance – Global NCAR Exchange Simplified
The International Medical Device Regulators Forum (IMDRF) has released the fifth edition of its guidance titled “ Medical Devices:...

Sharan Murugan
Apr 82 min read
35 views
0 comments


EMA Draft Guideline: Quality Aspects of mRNA Vaccines
The European Medicines Agency (EMA) has released a draft guideline outlining " Quality standards for mRNA Vaccines " , f ocusing on...

Sharan Murugan
Apr 82 min read
69 views
0 comments


SAHPRA Guideline: Section 21 Access to Unregistered Medicines
The South African Health Products Regulatory Authority (SAHPRA)Â has updated its Guideline " Section 21 Access to Unregistered Medicines "...

Sharan Murugan
Apr 63 min read
80 views
0 comments


Swissmedic’s Guidance: Packaging, Prior Notification Procedures, Fast-Track Authorisation, Regulatory Meetings & Temporary Authorisations
Swissmedic, the Swiss Agency for Therapeutic Products, has released multiple updated guidance documents in April 2025 that impact...

Sharan Murugan
Apr 62 min read
16 views
0 comments


EMA’s Reflection Paper: Linking to ePI from EU Medicine Packages – A Digital Leap in Patient Information
The European Medicines Agency (EMA) published on 31 March 2025 a draft " Reflection paper on linking to electronic Product Information...

Sharan Murugan
Apr 54 min read
40 views
0 comments


UK MHRA Guidance: National Assessment Procedure for Medicines, Submission and Assessment timetables for Innovative Medicines Applications
The Medicines and Healthcare Products Regulatory Agency (MHRA)Â has introduced a " National Assessment Procedure for Medicines " Â for...

Sharan Murugan
Apr 32 min read
66 views
0 comments


UK MHRA Guidance: Periodic Safety Update Reports (PSURs) for Medicinal Products
Ensuring the ongoing safety and efficacy of medicinal products is a cornerstone of pharmacovigilance. In the United Kingdom, the...

Sharan Murugan
Apr 13 min read
85 views
0 comments


UK MHRA: Guidance for Established Medicines -Marketing Authorisation Application Changes
The regulatory landscape for pharmaceuticals is constantly evolving, and the UK Medicines and Healthcare products Regulatory Agency...

Sharan Murugan
Apr 12 min read
24 views
0 comments